These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

866 related items for PubMed ID: 22630575

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
    Marschalkó M, Eros N, Holló P, Hársing J, Bottlik G, Bátai A, Csukly Z, Masszi T, Szentirmai Z, Fodor J, Kárpáti S, Matolcsy A, Csomor J.
    Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anaplastic large cell lymphoma: an unusual presentation in a 7-year-old girl.
    Ju E, Adigun C, Dunphy C, Gold S, Morrell DS.
    Pediatr Dermatol; 2012 Oct; 29(4):498-503. PubMed ID: 21967522
    [Abstract] [Full Text] [Related]

  • 7. ALK-negative systemic intravascular anaplastic large cell lymphoma presenting in the skin.
    Rieger KE, Polidore T, Warnke R, Kim J.
    J Cutan Pathol; 2011 Feb; 38(2):216-20. PubMed ID: 20236372
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
    Querfeld C, Khan I, Mahon B, Nelson BP, Rosen ST, Evens AM.
    Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.
    Kadin ME, Pinkus JL, Pinkus GS, Duran IH, Fuller CE, Onciu M, Kawaguchi H, Morris SW.
    Am J Surg Pathol; 2008 Sep; 32(9):1421-6. PubMed ID: 18670345
    [Abstract] [Full Text] [Related]

  • 16. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.
    Eckerle S, Brune V, Döring C, Tiacci E, Bohle V, Sundström C, Kodet R, Paulli M, Falini B, Klapper W, Chaubert AB, Willenbrock K, Metzler D, Bräuninger A, Küppers R, Hansmann ML.
    Leukemia; 2009 Nov; 23(11):2129-38. PubMed ID: 19657361
    [Abstract] [Full Text] [Related]

  • 17. A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult.
    Sridevi HB, Shanthala PR, Raghuveer CV, Prabhu AK, Akbar JK, Shivaprasad GS, Suresh PK, Navani S.
    J Cancer Res Ther; 2015 Nov; 11(3):656. PubMed ID: 26458652
    [Abstract] [Full Text] [Related]

  • 18. Intravascular ALK-negative anaplastic large cell lymphoma with localized cutaneous involvement and an indolent clinical course: toward recognition of a distinct clinicopathologic entity.
    Metcalf RA, Bashey S, Wysong A, Kim J, Kim YH, Gratzinger D.
    Am J Surg Pathol; 2013 Apr; 37(4):617-23. PubMed ID: 23480896
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.